Activating variants in <scp><i>PDGFRB</i></scp> result in a spectrum of disorders responsive to imatinib monotherapy

Tara Wenger(Seattle Children's Hospital), William B. Dobyns(Center for Infectious Disease Research), Jirat Chenbhanich(University of California, San Francisco), Shireen Ganapathi(Seattle Children's Hospital), Jonathan A. Perkins(Seattle Children's Hospital), David B. Everman(Greenwood Genetic Center), Jeanne Amiel(Hôpital Necker-Enfants Malades), Julie Park(Seattle Children's Hospital), Joseph T.C. Shieh(University of California, San Francisco), Randall A. Bly(Seattle Children's Hospital), Catherine M. Albert(Seattle Children's Hospital), Natalie Wu(University of California, San Francisco), Yuri A. Zárate(University of Kentucky), John Christodoulou(The University of Melbourne), Markus D. Boos(Seattle Children's Hospital), Anita E. Beck(Seattle Children's Hospital), Danny E. Miller(Seattle Children's Hospital), Anne Guimier(Hôpital Necker-Enfants Malades), Angela Sun(Seattle Children's Hospital), Margaret P Adam(University of Washington), Håkon Håkonarson(Children's Hospital of Philadelphia), Meredith Wilson(Children's Hospital at Westmead), Carrie L. Heike, Irene J. Chang(Seattle Children's Hospital), Elizabeth Bhoj(Children's Hospital of Philadelphia), John P. Dahl(Seattle Children's Hospital), Dong Li(Children's Hospital of Philadelphia), Deepti Gupta(Seattle Children's Hospital), Cynthia J. Curry(University Medical Center Groningen), Richard Webster(Sydney Children’s Hospitals Network), Elaine H. Zackai(Children's Hospital of Philadelphia)
American Journal of Medical Genetics Part A
June 5, 2020
Cited by 34


Related Papers